Related Experiment Video
Updated: Feb 25, 2026

Using the Protozoan Paramecium caudatum as a Vehicle for Food-borne Infections in Zebrafish Larvae
Published on: January 7, 2019
Prototheca: A Danger Underwater
Carolina Velez-Mejia1, Juan Velez-Londoño2
1Medical Student CES University, Medellin, Colombia.
Abstract:
Prototheca wickerhamii rarely causes systemic infection in humans but when it occurs, there are coexisting comorbidities. This case illustrated shows the manifestation of this opportunistic microorganism in an immunosuppressed patient. The patient was successfully treated with Liposomal amphotericin B with complete resolution of the lesions.
Insights
Prototheca wickerhamii rarely causes systemic infections in humans, often occurring in patients with comorbidities. This case highlights successful treatment of an immunosuppressed patient with lesions caused by this opportunistic alga.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunocompromised Hosts
Background:
- Prototheca wickerhamii is a rare cause of human infection, typically seen in immunocompromised individuals.
- Systemic infections by Prototheca wickerhamii are infrequent and often associated with underlying health conditions.
- Opportunistic infections pose significant challenges in managing immunocompromised patients.
Purpose of the Study:
- To illustrate the clinical manifestation of Prototheca wickerhamii infection in an immunosuppressed patient.
- To document the treatment and outcome of a rare systemic algal infection.
- To contribute to the understanding of Prototheca wickerhamii pathogenesis in vulnerable populations.
Main Methods:
- Case report of a single immunosuppressed patient.
- Clinical presentation and diagnostic findings were documented.
- Treatment response to antifungal therapy was monitored.
Main Results:
- The patient presented with lesions indicative of Prototheca wickerhamii infection.
- Successful treatment was achieved using Liposomal amphotericin B.
- Complete resolution of the lesions was observed post-treatment.
Conclusions:
- Liposomal amphotericin B is an effective treatment for Prototheca wickerhamii infections.
- Immunosuppression is a key risk factor for developing Prototheca wickerhamii infections.
- Early diagnosis and appropriate antifungal therapy are crucial for favorable outcomes.
Related Concept Videos
Diversity of Protists II
Diversity of Protists I
Diversity of Protists III
Bacterial Phylum Spirochaetes
Overview of Protists
Bacterial Phylum Planctomycetes

